ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Ansa Biotechnologies, an Emeryville, CA-based DNA synthesis platform provider, raised $71.5M in Series C funding on 18/11/2026. The round was led by Blue Water Life Science Advisors with participation from Illumina Ventures and others, bringing total capital to $211M for expanding manufacturing capacity.
Tap to vote and see what everyone thinks.
Summary by ByteBrief